RNN ~ Chang H. Ahn
Founder and Chairman
Dr. Chang H. Ahn is an internationally recognized drug development expert with over 20 years of experience in the fields of pharmacology and biotechnology. He founded Rexahn in 2001, and currently serves as the company’s Chairman and Chief Scientist. From 2001 to February 2013, Dr. Ahn also served as the company’s CEO. Prior, Dr. Ahn held dual positions as both Expert Regulatory Officer and Laboratory Chief at the FDA’s Center for Drug Evaluation and Research. While at the FDA, Dr. Ahn represented the agency in the fields of Antisense Oligonucleotide Therapeutics and Multi-Drug Resistance, and served a key role as both author and co-author of several FDA guidance documents. Before joining the FDA, Dr. Ahn carried out cancer research at the National Cancer Institute and Emory University’s School of Medicine. Dr. Ahn organized and chaired the U.S.-Korea Bio Business and Partnership Forum, of which Maryland State and Montgomery County are partners. He has also served as president of the Society of Biomedical Research since 2000.
